Re: Assessment of Late Lung Damage

By Parkins {dgDr.}C.S.  

International Journal of Radiation Biology, Vol. 55, Iss. 3, 1989-03 ,pp. : 479-481

Informa Healthcare

Access to resources Recommend Favorite

An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer

By Toh Chee-Keong   Lee Pyng   Chowbay Balram   Goh Jason   Mancer Kent   Tan Puay-Hoon  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 256-258

Informa Healthcare

Access to resources Recommend Favorite

EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy

By                

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 880-890

Spandidos Publications

Access to resources Recommend Favorite

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancermediated malignant pleural effusion

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2332-2340

Spandidos Publications

Access to resources Recommend Favorite

Expression of CA125 and cisplatin susceptibility of pleural effusion-derived human lung cancer cells from a Thai patient

By          

Oncology Letters, Vol. 4, Iss. 2, 2012-01 ,pp. : 252-256

Spandidos Publications

Access to resources Recommend Favorite